Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Tournaye

Showing results (141-150 of 268) with videos related to

Pageof 27
Sort By:
Plos One|November 4, 2020
Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysisGeorg Griesinger, Christophe Blockeel, Elke Kahler, et al.
Frontiers in Endocrinology|May 4, 2026
Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trialCaroline Roelens, Shari Mackens, Panagiotis Drakopoulos, et al.
Fertility and Sterility|May 17, 2003
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancyEfstratios M Kolibianakis, Carola Albano, Jarl Kahn, et al.
Therapeutic Advances in Reproductive Health|August 27, 2020
Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon conceptPanagiotis Drakopoulos, Erlisa Bardhi, Liese Boudry, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 22, 2021
Androgens and Anti-Müllerian Hormone in Infertile PatientsPanagiotis Drakopoulos, Erlisa Bardhi, Sebastian Scherer, et al.
Fertility and Sterility|August 17, 2011
High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injectionDimitra Kyrou, Efstratios M Kolibianakis, Human M Fatemi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunityKris Poppe, Daniel Glinoer, Herman Tournaye, et al.
Reproductive Biology and Endocrinology : RB&E|February 26, 2014
The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVMCarolina Ortega-Hrepich, Nikolaos P Polyzos, Ellen Anckaert, et al.
Reproductive Biomedicine Online|June 1, 2004
Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint systemKonstantinos A Zikopoulos, Efstratios M Kolibianakis, Peter Platteau, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 7, 2021
Correction to: Androgens and Anti-Müllerian Hormone in Infertile PatientsPanagiotis Drakopoulos, Erlisa Bardhi, Sebastian Scherer, et al.
Pageof 27

Showing results (141-150 of 268) with videos related to

Sort By:
Pageof 27
Plos One|November 4, 2020
Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysisGeorg Griesinger, Christophe Blockeel, Elke Kahler, et al.
Frontiers in Endocrinology|May 4, 2026
Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trialCaroline Roelens, Shari Mackens, Panagiotis Drakopoulos, et al.
Fertility and Sterility|May 17, 2003
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancyEfstratios M Kolibianakis, Carola Albano, Jarl Kahn, et al.
Therapeutic Advances in Reproductive Health|August 27, 2020
Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon conceptPanagiotis Drakopoulos, Erlisa Bardhi, Liese Boudry, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 22, 2021
Androgens and Anti-Müllerian Hormone in Infertile PatientsPanagiotis Drakopoulos, Erlisa Bardhi, Sebastian Scherer, et al.
Fertility and Sterility|August 17, 2011
High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injectionDimitra Kyrou, Efstratios M Kolibianakis, Human M Fatemi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunityKris Poppe, Daniel Glinoer, Herman Tournaye, et al.
Reproductive Biology and Endocrinology : RB&E|February 26, 2014
The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVMCarolina Ortega-Hrepich, Nikolaos P Polyzos, Ellen Anckaert, et al.
Reproductive Biomedicine Online|June 1, 2004
Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint systemKonstantinos A Zikopoulos, Efstratios M Kolibianakis, Peter Platteau, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 7, 2021
Correction to: Androgens and Anti-Müllerian Hormone in Infertile PatientsPanagiotis Drakopoulos, Erlisa Bardhi, Sebastian Scherer, et al.
Pageof 27